These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
416 related items for PubMed ID: 14975535
41. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials. Beattie WS, Wijeysundera DN, Karkouti K, McCluskey S, Tait G. Anesth Analg; 2008 Apr; 106(4):1039-48, table of contents. PubMed ID: 18349171 [Abstract] [Full Text] [Related]
45. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients. Vijan SG. J Indian Med Assoc; 2009 Mar; 107(3):178-82. PubMed ID: 19810392 [Abstract] [Full Text] [Related]
47. Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker. Chrysostomou A, Pedagogos E, MacGregor L, Becker GJ. Clin J Am Soc Nephrol; 2006 Mar; 1(2):256-62. PubMed ID: 17699214 [Abstract] [Full Text] [Related]
52. Beta-blocker therapy for congestive heart failure: a systemic overview and critical appraisal of the published trials. Avezum A, Tsuyuki RT, Pogue J, Yusuf S. Can J Cardiol; 1998 Aug; 14(8):1045-53. PubMed ID: 9738164 [Abstract] [Full Text] [Related]
55. Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials. Haas SJ, Vos T, Gilbert RE, Krum H. Am Heart J; 2003 Nov; 146(5):848-53. PubMed ID: 14597934 [Abstract] [Full Text] [Related]
56. ACE inhibitors and beta blockers in chronic congestive cardiac failure: therapeutic basis. Manoria PC, Manoria P. J Indian Med Assoc; 2003 May; 101(5):311-2, 315. PubMed ID: 14575221 [Abstract] [Full Text] [Related]
58. [ACE inhibitors, beta blockers, AT-1 antagonists in heart failure. Right dosage and combination]. Fliri M. MMW Fortschr Med; 2002 Nov 28; 144(48):38-43. PubMed ID: 12532542 [Abstract] [Full Text] [Related]
59. Neurohumoral effects of aliskiren in patients with symptomatic heart failure receiving a mineralocorticoid receptor antagonist: the Aliskiren Observation of Heart Failure Treatment study. Pitt B, Latini R, Maggioni AP, Solomon SD, Smith BA, Wright M, Prescott MF, McMurray JJ. Eur J Heart Fail; 2011 Jul 28; 13(7):755-64. PubMed ID: 21467028 [Abstract] [Full Text] [Related]
60. Association between mortality and persistent use of beta blockers and angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and coronary artery disease. Allen LaPointe NM, Zhou Y, Stafford JA, Hernandez AF, Kramer JM, Anstrom KJ. Am J Cardiol; 2009 Jun 01; 103(11):1518-24. PubMed ID: 19463509 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]